全文获取类型
收费全文 | 558篇 |
免费 | 37篇 |
出版年
2021年 | 8篇 |
2020年 | 4篇 |
2019年 | 8篇 |
2016年 | 5篇 |
2015年 | 17篇 |
2014年 | 26篇 |
2013年 | 27篇 |
2012年 | 28篇 |
2011年 | 31篇 |
2010年 | 16篇 |
2009年 | 16篇 |
2008年 | 15篇 |
2007年 | 21篇 |
2006年 | 16篇 |
2005年 | 13篇 |
2004年 | 18篇 |
2003年 | 20篇 |
2002年 | 10篇 |
2001年 | 13篇 |
2000年 | 23篇 |
1999年 | 22篇 |
1998年 | 6篇 |
1997年 | 6篇 |
1996年 | 6篇 |
1995年 | 9篇 |
1994年 | 7篇 |
1993年 | 3篇 |
1992年 | 10篇 |
1991年 | 10篇 |
1990年 | 11篇 |
1989年 | 12篇 |
1988年 | 15篇 |
1987年 | 10篇 |
1986年 | 7篇 |
1985年 | 11篇 |
1984年 | 9篇 |
1983年 | 4篇 |
1982年 | 6篇 |
1981年 | 4篇 |
1979年 | 6篇 |
1978年 | 3篇 |
1977年 | 7篇 |
1975年 | 6篇 |
1974年 | 7篇 |
1972年 | 4篇 |
1971年 | 3篇 |
1969年 | 6篇 |
1967年 | 5篇 |
1966年 | 10篇 |
1965年 | 3篇 |
排序方式: 共有595条查询结果,搜索用时 0 毫秒
91.
92.
93.
94.
95.
W. Arklay Steel 《BMJ (Clinical research ed.)》1935,1(3883):1165-1167
96.
Kristen M. Bullard Rebekah C. Gullberg Elnaz Soltani J. Jordan Steel Brian J. Geiss Susan M. Keenan 《PloS one》2015,10(6)
Arthropod-borne flavivirus infection continues to cause significant morbidity and mortality worldwide. Identification of drug targets and novel antiflaviviral compounds to treat these diseases has become a global health imperative. A previous screen of 235,456 commercially available small molecules identified the 2-thioxothiazolidin-4-one family of compounds as inhibitors of the flaviviral NS5 capping enzyme, a promising target for antiviral drug development. Rational drug design methodologies enabled identification of lead compound BG-323 from this series. We have shown previously that BG-323 potently inhibits NS5 capping enzyme activity, displays antiviral effects in dengue virus replicon assays and inhibits growth of West Nile and yellow fever viruses with low cytotoxicity in vitro. In this study we further characterized BG-323’s antiviral activity in vitro and in vivo. We found that BG-323 was able to reduce replication of WNV (NY99) and Powassan viruses in culture, and we were unable to force resistance into WNV (Kunjin) in long-term culture experiments. We then evaluated the antiviral activity of BG-323 in a murine model. Mice were challenged with WNV NY99 and administered BG-323 or mock by IP inoculation immediately post challenge and twice daily thereafter. Mice were bled and viremia was quantified on day three. No significant differences in viremia were observed between BG-323-treated and control groups and clinical scores indicated both BG-323-treated and control mice developed signs of illness on approximately the same day post challenge. To determine whether differences in in vitro and in vivo efficacy were due to unfavorable pharmacokinetic properties of BG-323, we conducted a pharmacokinetic evaluation of this small molecule. Insights from pharmacokinetic studies indicate that BG-323 is cell permeable, has a low efflux ratio and does not significantly inhibit two common cytochrome P450 (CYP P450) isoforms thus suggesting this molecule may be less likely to cause adverse drug interactions. However, the T1/2 of BG-323 was suboptimal and the percent of drug bound to plasma binding proteins was high. Future studies with BG-323 will be aimed at increasing the T1/2 and determining strategies for mitigating the effects of high plasma protein binding, which likely contribute to low in vivo efficacy. 相似文献
97.
98.
99.
Madhuri S. Salker Jaya Nautiyal Jennifer H. Steel Zoe Webster Sandra ?u?urovi? Marilena Nicou Yogesh Singh Emma S. Lucas Keisuke Murakami Yi-Wah Chan Sean James Yazan Abdallah Mark Christian B. Anne Croy Biserka Mulac-Jericevic Siobhan Quenby Jan J. Brosens 《PloS one》2012,7(12)
Decidualization renders the endometrium transiently receptive to an implanting blastocyst although the underlying mechanisms remain incompletely understood. Here we show that human endometrial stromal cells (HESCs) rapidly release IL-33, a key regulator of innate immune responses, upon decidualization. In parallel, differentiating HESCs upregulate the IL-33 transmembrane receptor ST2L and other pro-inflammatory mediators before mounting a profound anti-inflammatory response that includes downregulation of ST2L and increased expression of the soluble decoy receptor sST2. We demonstrate that HESCs secrete factors permissive of embryo implantation in mice only during the pro-inflammatory phase of the decidual process. IL-33 knockdown in undifferentiated HESCs was sufficient to abrogate this pro-inflammatory decidual response. Further, sequential activation of the IL-33/ST2L/sST2 axis was disordered in decidualizing HESCs from women with recurrent pregnancy loss. Signals from these cultures prolonged the implantation window but also caused subsequent pregnancy failure in mice. Thus, Il-33/ST2 activation in HESCS drives an autoinflammatory response that controls the temporal expression of receptivity genes. Failure to constrain this response predisposes to miscarriage by allowing out-of-phase implantation in an unsupportive uterine environment. 相似文献
100.